Pharma major Dr Reddy's Laboratories has appealed the government (govt) to denotify its Special Economic Zone (SEZ) at Medak in Andhra Pradesh. The formulations unit, which was to come up at Medak, will now be now shifted to Visakhapatnam where the company has another SEZ for manufacturing Active Pharmaceutical Ingredients (APIs) as the company wants to locate both its SEZs close together. The company is expected to invest around $200 million in both the SEZs.
Dr Reddy's had acquired around 103 hectares at Melasangam and Lingampally villages in Medak to set up a tablets and capsules manufacturing unit for exports. In Vizag, it had acquired around 260 acres for the bulk drugs SEZ, which will now house the formulation SEZ as well. However, the company despite shifting the formulation unit will retain the piece of land acquired at Medak and use it for other expansion plans.
The pharma company has given an undertaking to the Commerce Ministry for refunding the duty benefits availed of in the name of SEZ and the Development Commissioner of VSEZ has recommended the proposal. Further, the company is expected to take the matter for approval in the meeting of board of directors scheduled to be held on November 28, 2011.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1808.50 |
Dr. Reddys Lab | 1342.45 |
Cipla | 1472.45 |
Lupin | 2147.55 |
Zydus Lifesciences | 973.90 |
View more.. |